SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 15-12B - Securities registration termination [Section 12(b)]:
SEC Accession No. 0001193125-21-300045
Filing Date
2021-10-15
Accepted
2021-10-15 16:16:11
Documents
1
Effectiveness Date
2021-10-15

Document Format Files

Seq Description Document Type Size
1 15-12B d226700d1512b.htm 15-12B 11644
  Complete submission text file 0001193125-21-300045.txt   12703
Mailing Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053
Business Address 900 NORTHBROOK DRIVE, SUITE 200 TREVOSE PA 19053 (610) 254-9200
Strongbridge Biopharma plc (Filer) CIK: 0001634432 (see all company filings)

IRS No.: 981130690 | State of Incorp.: L2
Type: 15-12B | Act: 34 | File No.: 001-37569 | Film No.: 211326248
SIC: 2834 Pharmaceutical Preparations